ID: ALA3114861

Max Phase: Preclinical

Molecular Formula: C20H20ClNO5

Molecular Weight: 389.84

Molecule Type: Small molecule

Representations

Canonical SMILES:  O=C1N[C@H](C(=O)O)Cc2cccc(c2)OCCCCOc2ccc1c(Cl)c2

Standard InChI:  InChI=1S/C20H20ClNO5/c21-17-12-15-6-7-16(17)19(23)22-18(20(24)25)11-13-4-3-5-14(10-13)26-8-1-2-9-27-15/h3-7,10,12,18H,1-2,8-9,11H2,(H,22,23)(H,24,25)/t18-/m0/s1

Standard InChI Key:  NHZAXNNFKILNCX-SFHVURJKSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 389.84

Molecular Weight (Monoisotopic): 389.1030

AlogP: 3.32

#Rotatable Bonds: 1

Polar Surface Area: 84.86

Molecular Species: ACID

HBA: 4

HBD: 2

#RO5 Violations: 0

HBA (Lipinski): 6

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 3.34

CX Basic pKa:

CX LogP: 3.45

CX LogD: 0.03

Aromatic Rings: 2

Heavy Atoms: 27

QED Weighted: 0.78

Np Likeness Score: 0.84

References

1. Halland N, Blum H, Buning C, Kohlmann M, Lindenschmidt A..  (2014)  Small Macrocycles As Highly Active Integrin α2β1 Antagonists.,  5  (2): [PMID:24900800] [10.1021/ml4004556]

Source

Source(1):

• Scientific Literature